Here are four things to know.
1. Integra develops products for neurosurgery, reconstruction, wound and dental care.
2. Codman neurosurgery business — part of J&J’s DePuy Synthes unit — offers a portfolio of tissue ablation, spinal cord repair and cranial stabilization products.
3. Integra made a “binding offer” for the Codman business, although the deal is still pending approval from various works councils and regulators, a J&J spokeswoman told Reuters.
4. If approved by various works councils and regulators, the deal will close in the fourth quarter of 2017.
More articles on supply chain:
Skin cream costs vary based on prescribing provider, study finds
Hologic to acquire Cynosure for $1.6B: 3 things to know
Former FDA commissioner shares 4 thoughts on streamlining drug approvals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
